Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans

被引:8
作者
Katsifa, H
Tsaparidou, S
Diza, E
Gil-Lamaignere, C
Walsh, TJ
Roilides, E [1 ]
机构
[1] Aristotelian Univ Thessaloniki, Hippokrat Hosp, Dept Pediat 3, GR-54642 Thessaloniki, Greece
[2] Aristotelian Univ Thessaloniki, Dept Microbiol, GR-54006 Thessaloniki, Greece
[3] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2001年 / 31卷 / 03期
关键词
interleukin-13; monocyte; Candida albicans;
D O I
10.1111/j.1574-695X.2001.tb00522.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the effects of human interleukin-13 (IL-13) on human monocytes' (MNC) activities against Candida albicans, an important human pathogen. Increased phagocytosis of blastoconidia was observed after incubation with 50 U ml(-1) of IL-13 for 4 h or 48 h in the presence or absence of serum. The latter effect was inhibited by anti-IL-13 monoclonal antibody or mannose. Incubation of MNC with 50 U ml(-1) or IL-13 for 2 h significantly enhanced superoxide anion production in response to phorbol myristate acetate. IL-13 did not, however, alter the damage caused by MNC to hyphae, whereas it suppressed killing of blastoconidia. IL-13 has variable effects on MNC activities and may play an important immunoregulatory role against C albicans. (C) 2001 Federation of European Microbiological Societies. Published by Elsevier Science BN. All rights reserved.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 25 条
[1]   ACTIVATED MAST-CELLS PRODUCE INTERLEUKIN-13 [J].
BURD, PR ;
THOMPSON, WC ;
MAX, EE ;
MILLS, FC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1373-1380
[2]  
Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486
[3]  
COSENTINO G, 1995, J IMMUNOL, V155, P3145
[4]   STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
DANDREA, A ;
MA, XJ ;
ASTEAMEZAGA, M ;
PAGANIN, C ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :537-546
[5]   Disruption of filamentous actin inhibits human macrophage fusion [J].
DeFife, KM ;
Jenney, CR ;
Colton, E ;
Anderson, JM .
FASEB JOURNAL, 1999, 13 (08) :823-832
[6]   Interleukin-13 is an endothelial chemotaxin [J].
Halloran, MM ;
Haskell, CJ ;
Woods, JM ;
Hosaka, S ;
Koch, AE .
PATHOBIOLOGY, 1997, 65 (06) :287-292
[7]  
HART PH, 1995, CLIN EXP IMMUNOL, V99, P331
[8]   The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis [J].
Isomaki, P ;
Luukkainen, R ;
Toivanen, P ;
Punnonen, J .
ARTHRITIS AND RHEUMATISM, 1996, 39 (10) :1693-1702
[9]   Interleukin-13 is produced by activated human CD45RA(+) and CD45RO(+) T cells: Modulation by interleukin-4 and interleukin-12 [J].
Jung, T ;
Wijdenes, J ;
Neumann, C ;
deVries, JE ;
Yssel, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (03) :571-577
[10]  
KARBASSI A, 1987, J IMMUNOL, V139, P417